R&D Systems™ Recombinant Human Relaxin-2 (B-33/A-24) Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Relaxin-2 (B-33/A-24) Protein is derived from E. coli. The Recombinant Human Relaxin-2 (B-33/A-24) Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
• Gene ID (Entrez): 6019
• Molecular Weight (g/mol): 2.7 kDa (A chain), 3.9 kDa (B chain)
• Name: Relaxin-2 (B-33/A-24)
• Quantity: 25 μg
• Source: E. coli-derived human Relaxin-2 protein Val23-Arg55 (B chain),with an N-terminal Met & Gln162-Cys185 (A chain)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked heterodimer
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.